NSE filing, NSE: MONOPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Mono Pharmacare Ltd: key numbers
- Share price
- ₹9.20
- Market cap
- ₹16.26 Cr
- Revenue (annual)
- ₹165.7 Cr
- Net profit (annual)
- ₹0.73 Cr
- P/E (TTM)
- 22.2×Sector 45.9×
- Promoter holding
- 56.76%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mono Pharmacare Ltd
All →Mono Pharmacare Other Announcement
Mono Pharmacare declares non-applicability of the Regulation 27(2) corporate governance report for Q2 FY2026-27, as its shares are SME-listed. The filing is a routine compliance exemption notice with no business event.
Mono Pharmacare Other Announcement
Mono Pharmacare notified non-applicability of its Q1 FY27 corporate governance report under Reg 27(2). As an SME-listed entity, it is exempt under Reg 15(2)(b) of SEBI LODR.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited held its Annual General Meeting on September 30, 2026. Shareholders approved financial statements, director re-appointment, auditor appointment, and related party transactions.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.
Mono Pharmacare Legal & Regulatory
Mono Pharmacare received NSE fines totaling Rs. 0.02 Crore for non-compliance with SEBI Regulations 33 and 76. The Board has advised strengthening the company's compliance mechanism.
- Value
- ₹0.02 Cr
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.
Other management change announcements
All →Engineers India Management Change
Engineers India redesignated Anurag Sinha from Executive Director effective October 31, 2026. The change is reported as a senior management personnel change.
REC Management Change
REC Limited intimated that Executive Director J.K. Nayak ceased to hold that role effective 30 October 2026. He was appointed Chairman & Managing Director of IREDA.
Himadri Speciality Chemical Management Change
Himadri Speciality Chemical's board revised its senior management list following organisational restructuring. Six personnel are listed, including the CFO and Company Secretary.
HMT Management Change
HMT Ltd intimated the resignation of Aparna R, Assistant General Manager (F&A), who ceases as CFO and KMP effective close of business on October 30, 2026. Her resignation letter is attached.
Share India Securities Management Change
Share India Securities appointed Krishan Singh Barguzar as Non-Executive Independent Director for 36 months, effective 30 October 2026. He is a former SBI Chief General Manager.
Indian Renewable Energy Development Agency Management Change
IREDA appointed Jatin Kumar Nayak as CMD effective October 30, 2026. Dr. Bijay Kumar Mohanty ceased to hold the additional CMD charge that day.